To combat a noticeable trend in increased pricing of existing brand and specialty drugs by pharmaceutical manufactures this past year, Medical Mutual is implementing a new Drug Surveillance program, beginning July 1, 2017. The program will be for all groups and members with MMO’s prescription drug benefits. It is non-customizable by group, and the option to opt out of this drug management policy is not available. The program itself will be and enhanced version based on a standard Express Scripts offering.
Click here to learn more.
For more information, or to get appointed with Medical Mutual, contact a Cornerstone representative today.